United States - English - NLM (National Library of Medicine)

exelan pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown.

United States - English - NLM (National Library of Medicine)

cipla usa inc., - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. a

United States - English - NLM (National Library of Medicine)

unit dose services - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate tablet is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate tablets contain calcium acetate.  animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women.  patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] .  maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism.  calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are

United States - English - NLM (National Library of Medicine)

a-s medication solutions - calcium gluconate (unii: sqe6vb453k) (calcium cation - unii:2m83c4r6zb) - calcium gluconate 94 mg in 1 ml - calcium gluconate injection, usp is used to treat conditions arising from calcium deficiencies such as hypocalcemic tetany, hypocalcemia related to hypoparathyroidism and hypocalcemia due to rapid growth or pregnancy.  it is also used in the treatment of black widow spider bites to relieve muscle cramping and as an adjunct in the treatment of rickets, osteomalacia, lead colic and magnesium sulfate overdosage.  calcium gluconate has also been employed to decrease capillary permeability in allergic conditions, nonthrombocytopenic purpura and exudative dermatoses such as dermatitis herpetiformis and for pruritus of eruptions caused by certain drugs.  in hyperkalemia, calcium gluconate may aid in antagonizing the cardiac toxicity, provided the patient is not receiving digitalis therapy. calcium salts are contraindicated in patients with ventricular fibrillation or hypercalcemia.  intravenous administration of calcium is contraindicated when serum calcium levels are above normal.

United States - English - NLM (National Library of Medicine)

puretek corporation - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f*) during the period of tooth development results in a significant decrease in the incidence of dental caries. fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to 3 years of age and older living in areas where the drinking water fluoride content does not exceed 0.6 ppm f*. fluoride chewable tablets 0.5 mg are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f* and should not be administered to pediatric patients under 6 years of age when the fluoride content of drinking water is 0.3 ppm f* or to pediatric patients under age 3 years. do not administer fluoride chewable tablets (any strength) to pediatric patients under age 6 months.

United States - English - NLM (National Library of Medicine)

puretek corporation - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f*) during the period of tooth development results in a significant decrease in the incidence of dental caries. fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to 3 years of age and older living in areas where the drinking water fluoride content does not exceed 0.6 ppm f*. fluoride chewable tablets 0.25 mg are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f* and should not be administered to pediatric patients under 3 years of age when the fluoride content of drinking water is 0.3 ppm f* or more. do not administer fluoride chewable tablets (any strength) to pediatric patients under age 6 months.

United States - English - NLM (National Library of Medicine)

natural creations, inc. - sodium borate (unii: 91mbz8h3qo) (borate ion - unii:44oae30d22), calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), tribasic calcium phosphate (unii: 91d9gv0z28) (calcium cation - unii:2m83c4r6zb), eupatorium perfoliatum flowering top (unii: 1w0775vx6e) (eupatorium perfoliatum flowering top - unii:1w0775vx6e), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), hekla lava (unii: c21158iirk) (hekla lava - unii:c2 - borate ion 30 [hp_c] in 1 ml - uses: temporarily relieves back pain, joint pain, cracking in joints, swelling of joints, bone injuries, &/or other symptoms related to bone aches & pains other information: tamper seal: "sealed for your protection." do not use if seal is broken or missing. uses: temporarily relieves back pain, joint pain, cracking in joints, swelling of joints, bone injuries, &/or other symptoms related to bone aches & pains.

United States - English - NLM (National Library of Medicine)

washington homeopathic products - calcium fluoride 30c - to relieve the symptoms of joint pain. indications: calcium fluoride joint pain if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.

United States - English - NLM (National Library of Medicine)

dna labs, inc. - oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), calcium hypophosphite (unii: cui83r2732) (calcium cation - unii:2m83c4r6zb), tribasic calcium phosphate (unii: 91d9gv0z28) (phosphate ion - unii:nk08v8k8hr), hekla lava (unii: c21158iirk) (hekla lava - unii:c21158iirk), daphne mezereum bark (unii: x2n6e405gv) (daphne mezereum bark - unii:x2n6e405gv), mercuric oxide (un - supports healthy bones.

United States - English - NLM (National Library of Medicine)

pekana naturheilmittel gmbh - arnica montana root (unii: mue8y11327) (arnica montana root - unii:mue8y11327), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), calcium iodide (unii: 8eki9qee2h) (calcium cation - unii:2m83c4r6zb), clematis recta flowering top (unii: 396421sp9f) (clematis recta flowering top - unii:396421sp9f), scrophularia nodosa whole (unii: 7h443nub2t) (scrophularia nodosa whole - unii:7h443nub2t), conium maculatum flowering top (unii: q28r5gf371) (conium maculatum flowering top - unii:q28r5gf - helps cleanse and detoxify the body